Table 2.
Clinico-pathological parameters in relation to concordance of HER2 status.
| Parameter | Discordant GC | Concordant GC | p |
|---|---|---|---|
| Gender | |||
| Male | 9 | 58 | 0.1162 (NS) |
| Female | 1 | 40 | |
| Site | |||
| Lower | 5 | 47 | 0.1281 (NS) |
| Middle | 1 | 34 | |
| Upper | 4 | 17 | |
| Lauren Histotype | |||
| Intestinal | 5 | 57 | 0.5578 (NS) |
| Diffuse | 3 | 32 | |
| Mixed | 2 | 9 | |
| WHO histotype | |||
| Tubular | 5 | 57 | 0.5578 (NS) |
| Poorly cohesive | 3 | 32 | |
| Mixed | 2 | 9 | |
| Grade | |||
| Low | 6 | 49 | 0.7867 (NS) |
| High | 4 | 49 | |
| Stage | |||
| I–II | 4 | 36 | 0.8886 (NS) |
| III–IV | 6 | 62 | |
| T | |||
| 1–2 | 3 | 12 | 0.2862 (NS) |
| 3–4 | 7 | 86 | |
| N | |||
| 1 | 4 | 35 | 0.9388 (NS) |
| 2–3 | 6 | 63 | |
GC: Gastric carcinoma; NS: Not significant; T: Tumour; and N: Node.